|
|
||||||||
Ann Thorac Surg 1998;66:894-897
© 1998 The Society of Thoracic Surgeons
a Section of General Thoracic Surgery, Mayo Clinic and Mayo Foundation, Rochester, Minnesota, USA
Address reprint requests to Dr Trastek, Mayo Clinic, 200 First St, SW, Rochester, MN 55905
Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2628, 1998.
Background. This study examined the results of surgical treatment of leiomyosarcoma of the esophagus.
Methods. Between January 1920 and December 1996, 17 patients (9 men and 8 women) with leiomyosarcoma of the esophagus were treated surgically at the Mayo Clinic. Median age was 58 years and ranged from 26 to 76 years. Symptoms included dysphagia in 11 patients (64.7%) and odynophagia in 6 (35.3%). The tumor was located in the middle third of the esophagus in 10 patients (58.8%) and in the cervical esophagus in 7 (41.2%). Procedures performed included esophagogastrectomy in 9 patients (Ivor Lewis in 5, left thoracoabdominal in 3, and transhiatal in 1), enucleation in 3, transgastric excision in 1, and exploration without resection in 4.
Results. The procedure was considered curative in 11 patients (64.7%). There was one operative death (mortality, 5.9%). Complications occurred in 3 patients (17.6%) and included anastomotic leak in 2 and bleeding requiring reoperation in 1. Growth pattern was infiltrating in 7, polypoid in 5, and intramural in 5. Histologically, the tumor was grade 1 in 6 patients, grade 2 in 2, grade 3 in 7, and grade 4 in 2. The tumor was postsurgically classified as stage I in 2 patients, stage IIA in 7, stage IIB in 1, stage IIIA in 5, stage IV in 1, and unknown in 1. Six patients (35.3%) received adjuvant treatment. Follow-up was complete in 16 patients (94.1%) and ranged from 1 to 182 months (median, 48 months). Five- and 10-year actuarial survivals were 47.0% and 31.0%, respectively. Seven patients (41.2%) are currently alive (median survival, 72 months); all underwent curative resection. Factors affecting survival included completeness of resection, growth pattern, postsurgical stage, tumor grade, and tumor location (p < 0.05).
Conclusions. We conclude that leiomyosarcoma of the esophagus is rare. Complete resection provides long-term survival.
This article has been cited by other articles:
![]() |
R.S. Jutley, R.D. Gray, J.M. MacKenzie, and J.S. Cockburn A leiomyosarcoma of the oesophagus presenting incidentally without dysphagia Eur. J. Cardiothorac. Surg., January 1, 2002; 21(1): 127 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nakao, Y. Naomoto, K. Shigemitsu, Y. Shirakawa, T. Yamatsuji, M. Kataoka, M. Haisa, M. Takaoka, T. Fujiwara, H. Isozaki, et al. Leiomyosarcoma Arising in a Remnant Esophagus After Esophagectomy: a Case Report Jpn. J. Clin. Oncol., October 1, 2001; 31(10): 517 - 521. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |